You are here

THERAPYX, INC.

Company Information
Address
138 FARBER HALL 3435 MAIN STREET
BUFFALO, NY 14214-8001
United States



Information

UEI: CHPPVKPN2VE1

# of Employees: 6


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD

    Amount: $2,999,994.00

    Abstract TGF NanoCapis an oral combination of nanoparticulate transforming growth factor betaTGFand alltrans retinoic acidATRAin pre clinical development for treatment of inflammatory bowel diseaseIBD ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Oral sustained-release IL-10 microspheres for therapy of IBD

    Amount: $295,831.00

    Abstract The disorders collectively known as inflammatory bowel disease IBD including Crohn s disease CD and ulcerative colitis UC affect up to one and a half million Americans Both result from ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  3. Experimental Gonococcal Vaccine

    Amount: $271,000.00

    DESCRIPTION provided by applicant Genital tract infection with Neisseria gonorrhoeae gonorrhea does not induce a state of specific protective immunity and can be acquired repeatedly Despite publ ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  4. Therapy and Prophylaxis for Genital Tract Infection

    Amount: $1,498,000.00

    DESCRIPTION provided by applicant Genital tract infection with Neisseria gonorrhoeae gonorrhea does not induce a state of specific protective immunity and can be acquired repeatedly Despite publ ...

    SBIRPhase II2014Department of Health and Human Services National Institutes of Health
  5. A novel, multiparametric cardiac safety assay using human myocytes

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Genital tract infection with Neisseria gonorrhoeae (gonorrhea) does not induce a state of specific protective immunity and can be acquired repeatedly. Despite publ ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
  6. Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD

    Amount: $2,999,994.00

    DESCRIPTION (provided by applicant): Phase I studies established proof-of-principle for the efficacy of oral sustained-release TGF?1 (TPX-6001) and ATRA (TPX-7001) nanoparticles in the treatment of IB ...

    SBIRPhase II2011Department of Health and Human Services National Institutes of Health
  7. Co-encapsulation of IroN and IL-12 as an Extra-intestinal E. coli Vaccine.

    Amount: $292,501.00

    DESCRIPTION (provided by applicant): Despite recent advances in the treatment and prevention of infectious disease, the threat to world health continues to grow. The spread of new zoonotic viral stra ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  8. Delivery of Nanoencapsulated TGFbeta and ATRA for the Treatment of IBD

    Amount: $172,500.00

    DESCRIPTION (provided by applicant): The disorders collectively known as inflammatory bowel disease (IBD) include Crohn's disease (CD) and ulcerative colitis (UC) and affect up to one million people i ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  9. Treatment of Type 2 Diabetes with Oral Administration of Nanoencapsulated GLP-1

    Amount: $144,961.00

    DESCRIPTION (provided by applicant): Type 2 diabetes mellitus is one of the leading causes of death and disability in the world. While current treatments prevent some of diabetes' more damaging compli ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
  10. TUMOR IMMUNOTHERAPY WITH BIODEGRADABLE MICROSPHERES

    Amount: $0.00

    DESCRIPTION (provided by applicant): Proof of principle for the feasibility of our proprietary tumor vaccination strategy involving the use of Interleukin-12-encapsulated microspheres has been demo ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government